Planta Med
DOI: 10.1055/a-2654-6627
Original Papers

Nitidine Isolated from the Bark of Zanthoxylum myriacanthum and its Effects on NTERA-2 Cancer Stem Cells

Trieu Ha Phuong
2   University of Science and Technology of Hanoi (USTH), VAST, Hanoi, Vietnam
3   Institute of Biology (IB), VAST, Hanoi, Vietnam
,
Pham Minh Quan
1   Institute of Chemistry (ICH), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam
,
Pham Cao Bach
1   Institute of Chemistry (ICH), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam
,
Tran Thi Tuyen
1   Institute of Chemistry (ICH), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam
,
Nguyen Phuong Nga
2   University of Science and Technology of Hanoi (USTH), VAST, Hanoi, Vietnam
,
Nguyen Thi Cuc
3   Institute of Biology (IB), VAST, Hanoi, Vietnam
,
Do Thi Thao
3   Institute of Biology (IB), VAST, Hanoi, Vietnam
,
1   Institute of Chemistry (ICH), Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam
› Author Affiliations

This research is funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 104.01-2023.48.
Preview

Abstract

Nitidine (NIT) was isolated from the bark of Zanthoxylum myriacanthum and assessed for anti-proliferative effects on NTERA-2 cancer stem cells using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay, spheroid assay, DNA and lysosome staining, flow cytometry, caspase assay, immunoblotting, and molecular docking studies. Moreover, nitidine suppresses stemness properties like in vitro tumorsphere forming, c-myc, Oct4, Nanog proteins of NTERA-2 cancer stem cells after 48-hour treatment. Nitidine selectively induced anti-survival activities by triggering the intrinsic apoptotic process through p53 signaling and lysosome-dependent cell death (LDCD). The mechanism of action of nitidine on cancer stem cells was also investigated using molecular docking studies to provide physical insights. Molecular docking studies revealed that nitidine induces LDCD by effectively inhibiting the MHR1/2 domain of the TRPM2 protein on liposome membrane. These results suggested the potential capacity of nitidine in inhibiting cancer stem cells or tumor-initiating cells for therapeutic cancer application.

Supporting Information



Publication History

Received: 25 March 2025

Accepted after revision: 13 June 2025

Article published online:
23 July 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany